This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
4 Winning Consumer Staples Stock Bets for This Earnings Season
by Rajani Lohia
Efforts to boost productivity, improved pricing and marketing initiatives may have aided Consumer Staples companies in the September quarter, while high costs and macro factors are likely to have hurt.
Looking for a Growth Stock? 3 Reasons Why Church & Dwight (CHD) is a Solid Choice
by Zacks Equity Research
Church & Dwight (CHD) could produce exceptional returns because of its solid growth attributes.
Can Procter & Gamble (PG) Beat on Earnings Again in Q1?
by Zacks Equity Research
Procter & Gamble (PG) is likely to have witnessed positive trends in first-quarter fiscal 2020 on growth initiatives, including innovation, packaging and marketing efforts.
Coca-Cola (KO) to Report Q3 Earnings: What Should You Expect?
by Zacks Equity Research
Cola-Cola (KO) gains from the acceleration of sparkling soft drink category through investment and innovation. Further, its productivity and reinvestment program should drive growth.
Why Church & Dwight (CHD) Could Beat Earnings Estimates Again
by Zacks Equity Research
Church & Dwight (CHD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Top Ranked Growth Stocks to Buy for October 7th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, October 7th
Clorox (CLX) Introduces IGNITE Strategy, Trims FY20 Guidance
by Zacks Equity Research
Clorox (CLX) introduces IGNITE strategy, which is built on a sturdy foundation of its 2020 Strategy. It aims to innovate in all areas of the business. However, management lowers view for fiscal 2020.
Nu Skin's Customer Base Bodes Well, Mainland China is a Worry
by Zacks Equity Research
Nu Skin (NUS) is battling headwinds in Mainland China that led to an unimpressive view for 2019. However, a rising customer base bodes well.
Should You Invest in the Invesco DWA Consumer Staples Momentum ETF (PSL)?
by Zacks Equity Research
Sector ETF report for PSL
Lamb Weston (LW) Earnings Miss in Q1, Sales Improve Y/Y
by Zacks Equity Research
Lamb Weston's (LW) Q1 earnings and sales increase year over year, backed by improved volumes and price/mix across segments.
Church & Dwight up 9.2% in 6 Months, Strong Brands Add Gleam
by Zacks Equity Research
Church & Dwight's (CHD) robust brand portfolio is boosting market share across categories. However, weakness in the Specialty Products unit is a worry.
Colgate (CL) Displays a Solid Run-Up of More Than 20% YTD
by Zacks Equity Research
Colgate (CL) is benefiting from higher pricing, strong innovation and expansion efforts. Moreover, the company's savings programs are delivering impressive result.
Will Archer Daniels' Solid Growth Efforts Help Revive Stock?
by Zacks Equity Research
Archer Daniels' (ADM) weak Carbohydrate Solutions segment is concerning. However, the company's growth efforts including the Readiness program is likely to aid performance.
Here's Why Procter & Gamble is a Hot Investment Pick Now
by Zacks Equity Research
Procter & Gamble (PG) is benefiting from ongoing initiatives to improve productivity. Also, the company is focused on product improvement, packaging and marketing initiatives and cost-saving plans.
Church & Dwight Likely to Keep Gaining on Solid Sales Trend
by Zacks Equity Research
Church & Dwight's (CHD) sales are gaining from continued category growth and healthy market share gains. The company's consumer international business has long been contributing to the top line.
Prestige Consumer (PBH) Stock Down Despite Q1 Earnings Beat
by Zacks Equity Research
Prestige Consumer (PBH) delivers better-than-expected fiscal Q1 results, driven by solid consumption trends. However, both earnings and sales fall year over year.
Clorox (CLX) Q4 Earnings Top Estimates, Soft View Hurts Stock
by Zacks Equity Research
Clorox (CLX) reports mixed fourth-quarter fiscal 2019 results. Lower taxes and gross margin expansion aid its earnings while lower volume and unfavorable currency hurt sales.
Church & Dwight (CHD) Q2 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Church & Dwight's (CHD) earnings and sales improve in Q2, backed by gains from most product categories.
Church & Dwight (CHD) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 9.62% and 0.54%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Buy Procter & Gamble (PG) After Q4 Earnings Report?
by Christopher Vargas
Procter & Gamble (PG) reported its fiscal 2019 Q4 earnings before the opening bell on Tuesday.
Procter & Gamble (PG) Stock Up on Q4 Earnings & Sales Beat
by Zacks Equity Research
Procter & Gamble (PG) posts robust fourth-quarter fiscal 2019 results. Also, the company provided upbeat guidance for fiscal 2020.
What Awaits Corteva (CTVA) in its Debut Q2 Earnings Report?
by Zacks Equity Research
Digital efforts and product innovation are likely to benefit Corteva's (CVTA) second-quarter 2019 results. Further, it will gain from momentum in the seeds market.
Can Cost and Tariff Woes Mar Clorox's (CLX) Earnings in Q4?
by Zacks Equity Research
Clorox's (CLX) fourth-quarter fiscal 2019 results are likely to bear impacts of higher commodity costs, adverse currency, increased manufacturing and logistics expenses, and tariffs.
Why Archer Daniels' (ADM) Q2 Earnings Are Likely to Fall Y/Y
by Zacks Equity Research
Archer Daniels' (ADM) soft Carbohydrate Solutions unit due to impacts of adverse weather conditions, lower ethanol volumes and issues at Decatur complex is likely to hurt second-quarter 2019 results.
Will Cost Woes Hurt B&G Foods (BGS) This Earnings Season?
by Zacks Equity Research
Input costs related to freight and warehousing are likely to dent B&G Foods' (BGS) Q2 performance. Also, the Pirate Brands' divestiture is likely to dent sales.